Physician Wealth Advisors’s Lionsgate Studios LION Stock Holding History

Physician Wealth Advisors’s Portfolio LION Stock Details LION Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.21K	Sell	79 -42	-35%	-$543	﹤0.01%	1748
2026 Q1	$1.16K	Hold	121	–	–	﹤0.01%	1593
2025 Q4	$1.1K	Buy	+121	New	+$861	﹤0.01%	1556

Other funds holding LION

MFM

MHR Fund Management New York $1.92B AUM 119.57% 1-Year Est. Return

L7C

Liberty 77 Capital Washington, District of Columbia $1.75B AUM 88.73% 1-Year Est. Return

JCAM

Jericho Capital Asset Management New York $12.1B AUM 109.57% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Physician Wealth Advisors's LION Position: Q2 2026 in Review

Physician Wealth Advisors reduced its Lionsgate Studios (LION) stake by 35% in Q2 2026, selling an estimated $543 and leaving 79 shares worth $1.21K. The position accounts for ﹤0.01% of the portfolio, ranked #1748.

Physician Wealth Advisors first reported a position in LION in Q4 2025 and has held it in 3 quarters since. 293 funds tracked by Wall St. Rank hold LION as of Q2 2026.

Physician Wealth Advisors held 79 shares of Lionsgate Studios worth $1.21K as of Q2 2026.
Physician Wealth Advisors sold 42 Lionsgate Studios shares in Q2 2026, an estimated $543.
Lionsgate Studios made up ﹤0.01% of Physician Wealth Advisors's portfolio in Q2 2026, its #1748 holding.
Physician Wealth Advisors first reported a position in Lionsgate Studios in Q4 2025 and has held it in 3 quarters since.
293 funds tracked by Wall St. Rank held Lionsgate Studios as of Q2 2026.

Based on Physician Wealth Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.